Bifidobacterium infantis/lactobacillus acidophilus Interactions
There are 348 drugs known to interact with bifidobacterium infantis/lactobacillus acidophilus, along with 1 disease interaction. Of the total drug interactions, 348 are moderate.
- View all 348 medications that may interact with bifidobacterium infantis/lactobacillus acidophilus
- View bifidobacterium infantis/lactobacillus acidophilus disease interactions (1)
Most frequently checked interactions
View interaction reports for bifidobacterium infantis / lactobacillus acidophilus and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Ambien (zolpidem)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Calcium 600 D (calcium / vitamin d)
- Coenzyme Q10 (ubiquinone)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iron Sulfate (ferrous sulfate)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Nexium (esomeprazole)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zinc (zinc sulfate)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Bifidobacterium infantis/lactobacillus acidophilus disease interactions
There is 1 disease interaction with bifidobacterium infantis / lactobacillus acidophilus which include:
More about bifidobacterium infantis / lactobacillus acidophilus
- bifidobacterium infantis/lactobacillus acidophilus consumer information
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- Drug class: probiotics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.